Theriva Biologics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $758 | $0 |
Gross Profit | -38 | -39 | 719 | -134 |
EBITDA | -4,382 | -5,353 | -5,839 | -4,218 |
EBIT | -4,420 | -5,392 | -5,878 | -4,352 |
Net Income | -8,316 | -5,165 | -5,485 | -3,303 |
Net Change In Cash | 0 | 0 | 758 | 0 |
Free Cash Flow | -3,453 | -4,881 | -6,597 | -3,082 |
Cash | 16,593 | 18,261 | 23,177 | 31,160 |
Basic Shares | 775 | 685 | 685 | 681 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -135 | -268 | -87 | -201 |
EBITDA | -21,956 | -21,455 | -14,187 | -9,959 |
EBIT | -22,091 | -21,723 | -14,274 | -10,160 |
Net Income | -18,349 | -19,685 | -14,174 | -9,999 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -19,198 | -19,198 | -12,904 | -12,177 |
Cash | 23,177 | 41,786 | 67,325 | 6,227 |
Basic Shares | 644 | 613 | 12,187 | 1,901 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$10.75 |
2024-03-31 | -$0.30 |
2023-12-31 | -$0.34 |
2023-09-30 | -$0.19 |
